Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
Nature Medicine2015Vol. 21(5), pp. 512–517
Citations Over TimeTop 1% of 2015 papers
Caroline Bonner, Julie Kerr‐Conte, Valéry Gmyr, Gurvan Quéniat, Ericka Moerman, Julien Thévenet, Cédric Beaucamps, Nathalie Delalleau, Iuliana Popescu, Willy Malaisse, Abdullah Sener, Benoît Déprez, Amar Abderrahmani, Bart Staels, François Pattou
Related Papers
- → Type 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion(2015)43 cited
- → Pathways of Glucagon Secretion and Trafficking in the Pancreatic Alpha Cell: Novel Pathways, Proteins, and Targets for Hyperglucagonemia(2021)21 cited
- → Metabolic Studies and Glucagon Gel Filtration Pattern before and after Surgery in a Case of Glucagonoma Syndrome(1979)20 cited
- → Probing the intra‐islet control of beta cell function (1108.3)(2014)
- → 269-LB: Modeling Alpha-Cell Dysfunction Using Stem Cell–Derived Alpha Cells(2023)